Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
$19.15
-2.0%
$19.91
$14.84
$22.85
$5.22B1.129,386 shs9,875 shs
Masimo Co. stock logo
MASI
Masimo
$150.13
+0.1%
$158.42
$101.61
$194.88
$8.14B1.23651,386 shs311,070 shs
Sonova Holding AG stock logo
SONVY
Sonova
$64.22
-0.8%
$60.17
$52.83
$77.56
$19.15B1.3720,230 shs6,813 shs
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$124.25
+0.7%
$89.57
$55.00
$177.37
$4.20B1.911.36 million shs443,082 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
-1.99%-2.64%+0.16%-6.72%+11.47%
Masimo Co. stock logo
MASI
Masimo
+0.15%-3.53%-4.94%-11.67%+18.59%
Sonova Holding AG stock logo
SONVY
Sonova
-0.83%-4.85%+10.44%-0.67%+1.21%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
+0.74%+2.20%+34.60%+72.69%-9.29%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
N/AN/AN/AN/AN/AN/AN/AN/A
Masimo Co. stock logo
MASI
Masimo
4.8417 of 5 stars
4.43.00.04.23.63.31.3
Sonova Holding AG stock logo
SONVY
Sonova
1.9157 of 5 stars
0.05.00.80.02.20.01.9
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
1.2973 of 5 stars
1.41.00.00.02.92.51.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
0.00
N/AN/AN/A
Masimo Co. stock logo
MASI
Masimo
2.83
Moderate Buy$191.6027.62% Upside
Sonova Holding AG stock logo
SONVY
Sonova
2.00
HoldN/AN/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
2.82
Moderate Buy$126.701.97% Upside

Current Analyst Ratings Breakdown

Latest GNGBY, SONVY, MASI, and TMDX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/21/2025
Sonova Holding AG stock logo
SONVY
Sonova
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
5/9/2025
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$125.00 ➝ $130.00
5/9/2025
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$105.00 ➝ $125.00
5/7/2025
Masimo Co. stock logo
MASI
Masimo
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$193.00
5/7/2025
Masimo Co. stock logo
MASI
Masimo
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$215.00 ➝ $200.00
5/7/2025
Masimo Co. stock logo
MASI
Masimo
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$204.00 ➝ $185.00
5/7/2025
Masimo Co. stock logo
MASI
Masimo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$205.00 ➝ $190.00
4/29/2025
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$90.00 ➝ $105.00
4/25/2025
Sonova Holding AG stock logo
SONVY
Sonova
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeBuy
4/25/2025
Sonova Holding AG stock logo
SONVY
Sonova
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
4/23/2025
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold
(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
$3.29B1.59$1.51 per share12.72$10.53 per share1.82
Masimo Co. stock logo
MASI
Masimo
$2.13B3.83$4.88 per share30.74$25.79 per share5.82
Sonova Holding AG stock logo
SONVY
Sonova
$3.80B5.04$3.04 per share21.10$9.44 per share6.80
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$488.23M8.61$0.23 per share530.08$4.20 per share29.58
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
$154.96M$0.5133.60N/A4.71%9.84%5.36%7/18/2025 (Estimated)
Masimo Co. stock logo
MASI
Masimo
$81.50M-$9.17103.5432.43N/A3.85%14.98%6.95%8/5/2025 (Estimated)
Sonova Holding AG stock logo
SONVY
Sonova
$678.65MN/A0.0024.143.42N/AN/AN/AN/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
-$25.03M$1.36132.1886.89N/A8.14%18.74%4.39%7/30/2025 (Estimated)

Latest GNGBY, SONVY, MASI, and TMDX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
$0.29$0.70+$0.41$0.70$123.39 million$143.54 million
5/6/2025Q1 2025
Masimo Co. stock logo
MASI
Masimo
$1.24$1.36+$0.12-$3.12$367.79 million$372.00 million
4/22/2025Q1 2025
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
N/A$0.20N/A$0.10N/A$779.56 million
2/25/2025Q4 2024
Masimo Co. stock logo
MASI
Masimo
$1.42$1.80+$0.38-$6.52$593.35 million$600.70 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
$0.281.46%N/A54.90%N/A
Masimo Co. stock logo
MASI
Masimo
N/AN/AN/AN/AN/A
Sonova Holding AG stock logo
SONVY
Sonova
$0.570.89%N/AN/AN/A
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
N/AN/AN/AN/AN/A

Latest GNGBY, SONVY, MASI, and TMDX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/4/2025
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
$0.43264/24/20254/24/20255/14/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
0.06
0.78
0.50
Masimo Co. stock logo
MASI
Masimo
0.50
2.01
1.11
Sonova Holding AG stock logo
SONVY
Sonova
0.61
1.21
0.82
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
2.42
8.20
7.33

Institutional Ownership

CompanyInstitutional Ownership
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
N/A
Masimo Co. stock logo
MASI
Masimo
85.96%
Sonova Holding AG stock logo
SONVY
Sonova
0.01%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
99.67%

Insider Ownership

CompanyInsider Ownership
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
N/A
Masimo Co. stock logo
MASI
Masimo
16.90%
Sonova Holding AG stock logo
SONVY
Sonova
0.01%
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
7.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Getinge AB (publ) stock logo
GNGBY
Getinge AB (publ)
11,386272.37 millionN/ANot Optionable
Masimo Co. stock logo
MASI
Masimo
6,20054.22 million48.35 millionOptionable
Sonova Holding AG stock logo
SONVY
Sonova
18,151298.13 million298.10 millionNot Optionable
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
21033.82 million31.21 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Getinge AB (publ) stock logo

Getinge AB (publ) OTCMKTS:GNGBY

$19.15 -0.39 (-1.99%)
As of 05/23/2025 03:58 PM Eastern

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions. In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Masimo stock logo

Masimo NASDAQ:MASI

$150.13 +0.22 (+0.15%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$148.48 -1.66 (-1.10%)
As of 05/23/2025 05:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

Sonova stock logo

Sonova OTCMKTS:SONVY

$64.22 -0.54 (-0.83%)
As of 05/23/2025 03:59 PM Eastern

Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved in the design, development, manufacture, distribution, and service of hearing implants and related products under the Advanced Bionics brand. The company sells its products through independent distributors; and provides hearing care services through a network of stores and clinics. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.

TransMedics Group stock logo

TransMedics Group NASDAQ:TMDX

$124.25 +0.91 (+0.74%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$122.84 -1.41 (-1.14%)
As of 05/23/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.